يعرض 1 - 20 نتائج من 324 نتيجة بحث عن '"González Del Alba, A."', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المصدر: Prostate , 83 (4) pp. 376-384. (2023)

    وصف الملف: text

  4. 4
    Academic Journal

    المساهمون: Astellas Pharma, Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad (España), Fundación CRIS contra el Cáncer

    مصطلحات موضوعية: Prostate cancer, AR gain, AR-V7, CTCs, TMPRSS2-ERG, Enzalutamide

    وصف الملف: application/pdf

    Relation: Publisher's version; The underlying dataset has been published as supplementary material of the article in the publisher platform at DOI 10.1002/pros.24469; https://doi.org/10.1002/pros.24469; Sí; The Prostate 83(4): 376-384 (2023); http://hdl.handle.net/10261/333013; http://dx.doi.org/10.13039/501100004948; http://dx.doi.org/10.13039/501100003751; http://dx.doi.org/10.13039/501100004587; 2-s2.0-85145039209; https://api.elsevier.com/content/abstract/scopus_id/85145039209

  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: Institut Català de la Salut, Valderrama BP Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain. González-Del-Alba A Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. Morales-Barrera R Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Peláez Fernández I Medical Oncology Department, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain. Vázquez S Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain. Caballero Díaz C Medical Oncology Department, Hospital General Universitario de Valencia, Centro de Investigación Biomédica de Red en Cáncer (CIBERONC), Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Clinical and Translational Oncology;24; https://doi.org/10.1007/s12094-022-02815-w; Valderrama BP, González-Del-Alba A, Morales-Barrera R, Peláez Fernández I, Vázquez S, Caballero Díaz C, et al. SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021). Clin Transl Oncol. 2022 Apr;24:613–24.; https://hdl.handle.net/11351/7997; 000773969100003

  8. 8
    Academic Journal

    المساهمون: Institut Català de la Salut, Carles J Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Alonso-Gordoa T Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. Mellado B Medical Oncology Department, Hospital Clínic Barcelona, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Méndez-Vidal MJ Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain. Reina Sofía University Hospital (HURS), Córdoba, Spain. Vázquez S Lucus Augusti University Hospital, Lugo, Spain. González-del-Alba A Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain. Morales-Barrera R Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: European Journal of Cancer;173; https://doi.org/10.1016/j.ejca.2022.06.057; Carles J, Alonso-Gordoa T, Mellado B, Méndez-Vidal MJ, Vázquez S, González-del-Alba A, et al. Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial. Eur J Cancer. 2022 Sep;173:317–26.; https://hdl.handle.net/11351/8356

  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
    Academic Journal

    المساهمون: Gonzalez-del-Alba, Aranzazu Hosp Univ Puerta Hierro Majadahonda, Med Ongol Dept, Calle Joaquin Rodrigo 2, Madrid 28222, Spain, Puente, Javier Hosp Clin San Carlos, CIBERONC, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Med Oncol Dept, Madrid, Spain, Anido, Urbano Complejo Hosp Univ Santiago, Oncol Dept, Santiago De Compostela, Spain, Angel Climent, Miguel IVO, Med Oncol Dept, Valencia, Spain, Gonzalez-Billalabeitia, Enrique Univ Murcia, IMIB, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, Murcia, Spain, Gonzalez-Billalabeitia, Enrique Univ Catolica San Antonio Murcia UCAM, Murcia, Spain, Lainez, Nuria Complejo Hosp Navarra, Med Oncol Dept, Pamplona, Spain, Lambea, Julio Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Spain, Pablo Maroto, Jose Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain, Jose Mendez-Vidal, Maria Hosp Univ Reina Sofia, Med Oncol Dept, Cordoba, Spain, Montesa, Alvaro Hosp Reg Malaga, Med Oncol Dept, Malaga, Spain, Rodriguez, Angel Hosp Leon, Med Oncol Dept, Leon, Spain, Zambrana, Curro Hosp Univ Infanta Sofia, Med Oncol Dept, San Sebastian De Reyes, Spain, Sanofi

  17. 17
  18. 18
  19. 19
    Academic Journal
  20. 20